At FibroGen, we are dedicated to advancing first-in-class medicines that have the potential to provide new and effective treatment options to the patients who need them.
Before a new treatment can be made widely available, it must go through rigorous testing involving extensive preclinical and clinical studies. These studies are carefully conducted within guidelines set by the U.S. Food and Drug Administration (FDA) and corresponding regulatory authorities outside the U.S. The purpose of clinical trials is to evaluate the safety and effectiveness of promising new therapeutics. Patients who participate in clinical trials may gain access to investigational treatments before they are widely available, and play an important role in helping researchers and clinicians answer key questions about potential new products.